XML 85 R52.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based Compensation - Narrative (Details) - USD ($)
12 Months Ended
Dec. 27, 2019
Aug. 26, 2019
Apr. 01, 2019
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Aug. 25, 2019
Mar. 31, 2017
Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Exercise price (in USD per share)       $ 9.25 $ 14.46 $ 9.84   $ 5.06  
Options vested and unvested outstanding (in shares)       7,723,302 5,396,465 3,549,405   1,525,857  
Vested options (in shares)       3,009,080 1,581,810 502,361      
Accelerated vesting of awards       $ 1,800,000 $ 10,200,000        
Unrecognized share-based compensation       $ 52,300,000          
Unrecognized share-based compensation, period for recognition       2 years 8 months 12 days          
Stock Options Repriced                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Repricing ratio   1              
Exercise price (in USD per share)   $ 7.78              
Options vested and unvested outstanding (in shares)   5,095,013              
Stock-based compensation expense   $ 9,200,000              
Stock Options Repriced | Executives, Subject to Exercise Restriction Period                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vested executive options subject to one-year restriction period (in shares)   735,428              
Restriction period   1 year              
Stock Options                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Threshold percentage of total voting power of the company       10.00%          
Exercise price as a percentage of fair value       110.00%          
Contractual term       5 years          
Accelerated vesting of awards (in shares) 849,212                
Accelerated vesting of awards $ 11,200,000                
Restricted Share Awards                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Awards vested during period       $ 1,400,000 1,400,000 $ 2,500,000      
Restricted Stock Units                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Awards vested during period       $ 200,000 $ 100,000 $ 0      
Performance Shares                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Accelerated vesting of awards (in shares) 108,640                
Accelerated vesting of awards $ 800,000                
Awards granted (in shares)   408,510              
Unvested awards (in shares)       299,870          
Performance Shares, Time-Based Vesting                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Awards granted (in shares)   272,338              
Share of awards granted   66.66%              
Performance Shares, Vesting Based Upon Clinical Trial and Regulatory Milestones                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Awards granted (in shares)   136,172              
Share of awards granted   33.33%              
2016 Equity Incentive Plan                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Common shares reserved for grant (in shares)       1,500,000         4,500,000
Common shares reserved for grant, annual percentage increase                 4.00%
Increase in common shares reserved for grant (in shares)     2,900,000            
Minimum | Stock Options Repriced                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Exercise price (in USD per share)             $ 8.82    
Maximum | Stock Options Repriced                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Exercise price (in USD per share)             24.44    
Median | Stock Options Repriced                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Exercise price (in USD per share)             $ 17.28